FDA inspection
McKesson Corporation dba RxPak: FDA inspection ending Aug 14, 2002
FDA inspection 231425 · No Action Indicated (NAI) · Memphis, TN
Key facts
| Inspection ID | 231425 |
|---|---|
| Firm | McKesson Corporation dba RxPak |
| FEI number | 3002574153 |
| Address | 4971 Southridge Blvd Ste 111-115 |
| City | Memphis |
| State | TN |
| ZIP | 38141-8314 |
| Fiscal year | 2002 |
| Inspection end date | Aug 14, 2002 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data